Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma
SiliconANGLE ·
Chai Discovery Inc., a company that develops artificial intelligence models to predict interactions between biochemical molecules, today announced it has raised $400 million in Series C funding, nearly tripling its valuation to $3.8...